BioCentury
ARTICLE | Financial News

Erytech seeking NASDAQ listing

October 9, 2017 11:41 PM UTC

Erytech Pharma S.A. (Euronext:ERYP) proposed to raise up to $100 million in a NASDAQ listing and concurrent private placement. Jefferies, Cowen, Oddo BHF and JMP Securities are the listing's underwriters. The company will offer the private placement to investors in Europe and other countries outside of the U.S. and Canada.

This month, Erytech plans to resubmit an MAA to EMA for Graspa eryaspase to treat relapsed or refractory acute lymphoblastic leukemia (ALL). The company withdrew an MAA in November 2016. By 3Q18, Erytech also plans to start Phase III studies of Graspa to treat pancreatic cancer and ALL...

BCIQ Company Profiles

Erytech Pharma S.A.